Shares of our common stock are listed on the NASDAQ OTC market and trade under the symbol “UEEC“.
For more information, please contact investor@uhpcorp.com
For press and media relations, please contact media@uhpcorp.com
Press Releases
-
United Health Products Reports on Product Testing for FDA Application
Mesquite, Nevada – August 3, 2023 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval application process. Due to further unanticipated delays in testing performed by external service providers the company continues to await testing reports necessary for the preparation and filing of its revised PMA application.…
-
United Health Products Reports on Progress in Product Testing
Mesquite, Nevada – June 27, 2023 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval application process. As previously disclosed, UHP is conducting FDA required testing on its packaged products in collaboration with the company’s U.S. based, FDA certified packaging partner. The test protocol is designed to…
-
United Health Products Reiterates Guidance on FDA PMA Application Process
Mesquite, Nevada – June 7, 2023 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval application process. As disclosed in a press release on March 29, 2023, UHP has produced additional batches of its HemoStyp hemostatic gauze to demonstrate consistency and uniformity of its manufacturing process as…
-
United Health Products Provides Update on FDA PMA Application Process
Mesquite, Nevada – March 29, 2023 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval application process. As disclosed in a press release on January 31, 2023, UHP produced three batch lots of its HemoStyp gauze product to demonstrate consistent manufacturing results, which the company believes to…